SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001640334-20-001960
Filing Date
2020-08-05
Accepted
2020-08-04 20:00:01
Documents
6
Period of Report
2020-07-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K embi_8k.htm 8-K 18935
2 EX-4.1 embi_ex41.htm EX-4.1 88043
3 EX-4.2 embi_ex42.htm EX-4.2 84410
4 EX-10.1 embi_ex101.htm EX-10.1 177456
5 EX-99.1 embi_ex991.htm EX-99.1 8106
6 embi_ex991img1.jpg GRAPHIC 5447
  Complete submission text file 0001640334-20-001960.txt   386020
Mailing Address 130 NORTH MARINA DRIVE LONG BEACH CA 90803
Business Address 130 NORTH MARINA DRIVE LONG BEACH CA 90803 (949) 336-3443
Emerald Bioscience, Inc. (Filer) CIK: 0001516551 (see all company filings)

IRS No.: 450692882 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55136 | Film No.: 201075165
SIC: 2834 Pharmaceutical Preparations